OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 02, 2011
Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.
Brazil develops its first national plasma fractionation plant.
A single, global tooling standard would offer many benefits, but one has been slow to emerge.
Q&A with Robert Hardy, chief executive of Aesica
The author provides an overview of QbD implmentation for biopharmaceuticals.
The power of emerging markets is reflected in the pharma's sales and production positions.
As drug shortages make headlines, FDA tests the Sentinel safety system and its efect on healthcare.
INTERPHEX 2011 aims to address the industry's unique characteristics.
February 24, 2011
Gilead to Acquire Calistoga; Bayer Healthcare Appoints Former Pfizer Exec; and More.
February 17, 2011
Company and People Notes: sanofi to Acquire Genzyme; Lilly Makes Senior Appointments; and More.